Publisher Logo
sales@marketinsights.report
Report banner
Hydronephrosis Treatment Market
Updated On

Jan 29 2025

Total Pages

230

Hydronephrosis Treatment Market Strategic Market Roadmap: Analysis and Forecasts 2025-2033

Hydronephrosis Treatment Market by Type (Unilateral hydronephrosis, Bilateral hydronephrosis), by Indication (Intrinsic, Extrinsic), by Diagnosis (Laboratory tests, Imaging), by Treatment (Shock wave lithotripsy, Laparoscopy, Bladder catheterization, Steroid therapy, Other treatment types), by Age Group (Adult, Pediatric), by North America (U.S., Canada), by Europe (Germany, UK, France, Italy, Spain, Rest of Europe), by Asia Pacific (China, Japan, India, Australia, South Korea, Rest of Asia Pacific), by Latin America (Brazil, Mexico, Argentina, Rest of Latin America), by Middle East and Africa (Saudi Arabia, South Africa, UAE, Rest of Middle East and Africa) Forecast 2025-2033

Publisher Logo

Hydronephrosis Treatment Market Strategic Market Roadmap: Analysis and Forecasts 2025-2033

Key Insights

The size of the Hydronephrosis Treatment market was valued at USD XXX Billion in 2023 and is projected to reach USD XXX Billion by 2032, with an expected CAGR of 8.2% during the forecast period.Hydronephrosis is a medical condition where swelling of the kidney occurs because of a blockage in the urinary tract leading to difficulty in the normal passage of urine. Various clinical factors cause hydronephrosis such as kidney stones, tumors, infections, or even congenital abnormalities. The hydronephrosis treatment market comprises a wide array of clinical interventions and procedures that work to treat the underlying clinical cause for this blockage and reverse the normal flow of urine. The treatments can range from medication to minimally invasive procedures and surgical interventions. Some of the drivers of this market include the growing incidence of kidney diseases, advancement in minimally invasive surgical techniques, and increasing demand for effective and less invasive treatment options.

Hydronephrosis Treatment Market Research Report - Market Size, Growth & Forecast

Hydronephrosis Treatment Market Concentration & Characteristics

The Hydronephrosis Treatment Market is moderately concentrated, with the top 10 players accounting for around 60% of the market share. The market is characterized by innovation, with a focus on developing less invasive and more effective treatments for hydronephrosis.

The key regulations impacting the market include the FDA regulations in the US and the EMA regulations in Europe. These regulations govern the safety and efficacy of hydronephrosis treatment products and devices.

The market is also characterized by the presence of product substitutes, such as open surgery and conservative management. However, the growing demand for minimally invasive procedures and the technological advancements in imaging and treatment modalities are expected to reduce the market share of these substitutes.

Hydronephrosis Treatment Market Trends

The key market trends include the increasing adoption of minimally invasive procedures, the growing use of imaging technologies, and the development of new drug therapies. These trends are expected to drive the growth of the market in the coming years.

The adoption of minimally invasive procedures is growing due to the reduced risk of complications, shorter recovery time, and better cosmetic outcomes. These procedures, such as laparoscopy and robotic surgery, are increasingly used to treat hydronephrosis, especially in pediatric patients.

The use of imaging technologies is also growing due to the need for accurate diagnosis and monitoring of hydronephrosis. Imaging techniques, such as ultrasound, CT scans, and MRI, are used to visualize the kidneys and ureters and identify the underlying cause of hydronephrosis.

The development of new drug therapies is also contributing to the growth of the market. These drugs, such as diuretics and antibiotics, are used to manage the symptoms and underlying causes of hydronephrosis, such as urinary tract infections and kidney stones.

Hydronephrosis Treatment Market Growth

Key Region or Country & Segment to Dominate the Market

North America is the largest market for hydronephrosis treatment, followed by Europe and Asia Pacific. The high prevalence of kidney diseases, the advanced healthcare infrastructure, and the presence of key market players are the major factors driving the growth of the market in these regions.

The adult segment is expected to dominate the market during the forecast period due to the higher prevalence of hydronephrosis in adults compared to pediatric patients.

Hydronephrosis Treatment Market Product Insights Report Coverage & Deliverables

The Hydronephrosis Treatment Market Product Insights Report Coverage & Deliverables includes:

  • Market size and growth analysis
  • Market share analysis
  • Key market trends
  • Competitive landscape
  • Product portfolio analysis
  • Key market developments

Hydronephrosis Treatment Market Analysis

The Hydronephrosis Treatment Market is expected to grow at a CAGR of 8.2% during the forecast period (2023-2030). The growth of the market is driven by factors such as the increasing prevalence of kidney diseases, the rising demand for minimally invasive procedures, and the technological advancements in imaging and treatment modalities.

The market size is expected to reach 4.2 Billion by 2030, from 2.4 Billion in 2023. North America is the largest market for hydronephrosis treatment, followed by Europe and Asia Pacific.

Driving Forces: What's Propelling the Hydronephrosis Treatment Market

  • Increasing prevalence of kidney diseases
  • Rising demand for minimally invasive procedures
  • Technological advancements in imaging and treatment modalities

Challenges and Restraints in Hydronephrosis Treatment Market

  • High cost of treatment
  • Lack of awareness about hydronephrosis
  • Limited access to healthcare services in developing countries

Emerging Trends in Hydronephrosis Treatment Market

  • Adoption of artificial intelligence in diagnosis and treatment
  • Development of personalized treatment plans
  • Growing focus on preventive care

Hydronephrosis Treatment Industry News

  • In June 2023, Novartis AG bolstered its innovative medicines strategy and renal pipeline by acquiring Chinook Therapeutics. This acquisition may expand the company’s drug portfolio to target kidney disease treatment.

Leading Players in the Hydronephrosis Treatment Market

Hydronephrosis Treatment Market Segmentation

1. Type

  • 1.1. Unilateral hydronephrosis
  • 1.2. Bilateral hydronephrosis

2. Indication

  • 2.1. Intrinsic
    • 2.1.1. Acute unilateral obstructive uropathy
    • 2.1.2. Kidney stone
    • 2.1.3. Bladder cancer
    • 2.1.4. Bladder stones
    • 2.1.5. Urethral stricture
    • 2.1.6. Pelvic organ prolapse
    • 2.1.7. Other intrinsic indications
  • 2.2. Extrinsic
    • 2.2.1. Retroperitoneal fibrosis
    • 2.2.2. Ovarian vein syndrome
    • 2.2.3. Other extrinsic indications

3. Diagnosis

  • 3.1. Laboratory tests
    • 3.1.1. Urinalysis
    • 3.1.2. Complete blood count
    • 3.1.3. Electrolyte analysis
    • 3.1.4. Other laboratory tests
  • 3.2. Imaging
    • 3.2.1. Ultrasound
    • 3.2.2. Intravenous pyelography
    • 3.2.3. KUB X-Rays
    • 3.2.4. CT-scan
    • 3.2.5. Other imaging types

4. Treatment

  • 4.1. Shock wave lithotripsy
  • 4.2. Laparoscopy
  • 4.3. Bladder catheterization
  • 4.4. Steroid therapy
  • 4.5. Other treatment types

5. Age Group

  • 5.1. Adult
  • 5.2. Pediatric

Hydronephrosis Treatment Market Segmentation By Geography

1. North America

  • 1.1. U.S.
  • 1.2. Canada

2. Europe

  • 2.1. Germany
  • 2.2. UK
  • 2.3. France
  • 2.4. Italy
  • 2.5. Spain
  • 2.6. Rest of Europe

3. Asia Pacific

  • 3.1. China
  • 3.2. Japan
  • 3.3. India
  • 3.4. Australia
  • 3.5. South Korea
  • 3.6. Rest of Asia Pacific

4. Latin America

  • 4.1. Brazil
  • 4.2. Mexico
  • 4.3. Argentina
  • 4.4. Rest of Latin America

5. Middle East and Africa

  • 5.1. Saudi Arabia
  • 5.2. South Africa
  • 5.3. UAE
  • 5.4. Rest of Middle East and Africa

Hydronephrosis Treatment Market Regional Share

Hydronephrosis Treatment Market REPORT HIGHLIGHTS

AspectsDetails
Study Period 2019-2033
Base Year 2024
Estimated Year 2025
Forecast Period2025-2033
Historical Period2019-2024
Growth RateCAGR of 8.2% from 2019-2033
Segmentation
    • By Type
      • Unilateral hydronephrosis
      • Bilateral hydronephrosis
    • By Indication
      • Intrinsic
        • Acute unilateral obstructive uropathy
        • Kidney stone
        • Bladder cancer
        • Bladder stones
        • Urethral stricture
        • Pelvic organ prolapse
        • Other intrinsic indications
      • Extrinsic
        • Retroperitoneal fibrosis
        • Ovarian vein syndrome
        • Other extrinsic indications
    • By Diagnosis
      • Laboratory tests
        • Urinalysis
        • Complete blood count
        • Electrolyte analysis
        • Other laboratory tests
      • Imaging
        • Ultrasound
        • Intravenous pyelography
        • KUB X-Rays
        • CT-scan
        • Other imaging types
    • By Treatment
      • Shock wave lithotripsy
      • Laparoscopy
      • Bladder catheterization
      • Steroid therapy
      • Other treatment types
    • By Age Group
      • Adult
      • Pediatric
  • By Geography
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • UK
      • France
      • Italy
      • Spain
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • Australia
      • South Korea
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
    • Middle East and Africa
      • Saudi Arabia
      • South Africa
      • UAE
      • Rest of Middle East and Africa
Table Of Content
  1. 1. Introduction
    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions
  2. 2. Executive Summary
    • 2.1. Introduction
  3. 3. Market Dynamics
    • 3.1. Introduction
      • 3.2. Market Drivers
        • 3.2.1 Rising prevalence of kidney diseases
        • 3.2.2 Increasing patient population related to urinary tract infections
        • 3.2.3 Growing demand for minimally invasive procedures
        • 3.2.4 Increasing adoption of advanced imaging techniques for diagnosis
      • 3.3. Market Restrains
        • 3.3.1. Lack of awareness and high treatment cost
      • 3.4. Market Trends
  4. 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  5. 5. Global Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 5.1. Market Analysis, Insights and Forecast - by Type
      • 5.1.1. Unilateral hydronephrosis
      • 5.1.2. Bilateral hydronephrosis
    • 5.2. Market Analysis, Insights and Forecast - by Indication
      • 5.2.1. Intrinsic
        • 5.2.1.1. Acute unilateral obstructive uropathy
        • 5.2.1.2. Kidney stone
        • 5.2.1.3. Bladder cancer
        • 5.2.1.4. Bladder stones
        • 5.2.1.5. Urethral stricture
        • 5.2.1.6. Pelvic organ prolapse
        • 5.2.1.7. Other intrinsic indications
      • 5.2.2. Extrinsic
        • 5.2.2.1. Retroperitoneal fibrosis
        • 5.2.2.2. Ovarian vein syndrome
        • 5.2.2.3. Other extrinsic indications
    • 5.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 5.3.1. Laboratory tests
        • 5.3.1.1. Urinalysis
        • 5.3.1.2. Complete blood count
        • 5.3.1.3. Electrolyte analysis
        • 5.3.1.4. Other laboratory tests
      • 5.3.2. Imaging
        • 5.3.2.1. Ultrasound
        • 5.3.2.2. Intravenous pyelography
        • 5.3.2.3. KUB X-Rays
        • 5.3.2.4. CT-scan
        • 5.3.2.5. Other imaging types
    • 5.4. Market Analysis, Insights and Forecast - by Treatment
      • 5.4.1. Shock wave lithotripsy
      • 5.4.2. Laparoscopy
      • 5.4.3. Bladder catheterization
      • 5.4.4. Steroid therapy
      • 5.4.5. Other treatment types
    • 5.5. Market Analysis, Insights and Forecast - by Age Group
      • 5.5.1. Adult
      • 5.5.2. Pediatric
    • 5.6. Market Analysis, Insights and Forecast - by Region
      • 5.6.1. North America
      • 5.6.2. Europe
      • 5.6.3. Asia Pacific
      • 5.6.4. Latin America
      • 5.6.5. Middle East and Africa
  6. 6. North America Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 6.1. Market Analysis, Insights and Forecast - by Type
      • 6.1.1. Unilateral hydronephrosis
      • 6.1.2. Bilateral hydronephrosis
    • 6.2. Market Analysis, Insights and Forecast - by Indication
      • 6.2.1. Intrinsic
        • 6.2.1.1. Acute unilateral obstructive uropathy
        • 6.2.1.2. Kidney stone
        • 6.2.1.3. Bladder cancer
        • 6.2.1.4. Bladder stones
        • 6.2.1.5. Urethral stricture
        • 6.2.1.6. Pelvic organ prolapse
        • 6.2.1.7. Other intrinsic indications
      • 6.2.2. Extrinsic
        • 6.2.2.1. Retroperitoneal fibrosis
        • 6.2.2.2. Ovarian vein syndrome
        • 6.2.2.3. Other extrinsic indications
    • 6.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 6.3.1. Laboratory tests
        • 6.3.1.1. Urinalysis
        • 6.3.1.2. Complete blood count
        • 6.3.1.3. Electrolyte analysis
        • 6.3.1.4. Other laboratory tests
      • 6.3.2. Imaging
        • 6.3.2.1. Ultrasound
        • 6.3.2.2. Intravenous pyelography
        • 6.3.2.3. KUB X-Rays
        • 6.3.2.4. CT-scan
        • 6.3.2.5. Other imaging types
    • 6.4. Market Analysis, Insights and Forecast - by Treatment
      • 6.4.1. Shock wave lithotripsy
      • 6.4.2. Laparoscopy
      • 6.4.3. Bladder catheterization
      • 6.4.4. Steroid therapy
      • 6.4.5. Other treatment types
    • 6.5. Market Analysis, Insights and Forecast - by Age Group
      • 6.5.1. Adult
      • 6.5.2. Pediatric
  7. 7. Europe Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 7.1. Market Analysis, Insights and Forecast - by Type
      • 7.1.1. Unilateral hydronephrosis
      • 7.1.2. Bilateral hydronephrosis
    • 7.2. Market Analysis, Insights and Forecast - by Indication
      • 7.2.1. Intrinsic
        • 7.2.1.1. Acute unilateral obstructive uropathy
        • 7.2.1.2. Kidney stone
        • 7.2.1.3. Bladder cancer
        • 7.2.1.4. Bladder stones
        • 7.2.1.5. Urethral stricture
        • 7.2.1.6. Pelvic organ prolapse
        • 7.2.1.7. Other intrinsic indications
      • 7.2.2. Extrinsic
        • 7.2.2.1. Retroperitoneal fibrosis
        • 7.2.2.2. Ovarian vein syndrome
        • 7.2.2.3. Other extrinsic indications
    • 7.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 7.3.1. Laboratory tests
        • 7.3.1.1. Urinalysis
        • 7.3.1.2. Complete blood count
        • 7.3.1.3. Electrolyte analysis
        • 7.3.1.4. Other laboratory tests
      • 7.3.2. Imaging
        • 7.3.2.1. Ultrasound
        • 7.3.2.2. Intravenous pyelography
        • 7.3.2.3. KUB X-Rays
        • 7.3.2.4. CT-scan
        • 7.3.2.5. Other imaging types
    • 7.4. Market Analysis, Insights and Forecast - by Treatment
      • 7.4.1. Shock wave lithotripsy
      • 7.4.2. Laparoscopy
      • 7.4.3. Bladder catheterization
      • 7.4.4. Steroid therapy
      • 7.4.5. Other treatment types
    • 7.5. Market Analysis, Insights and Forecast - by Age Group
      • 7.5.1. Adult
      • 7.5.2. Pediatric
  8. 8. Asia Pacific Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 8.1. Market Analysis, Insights and Forecast - by Type
      • 8.1.1. Unilateral hydronephrosis
      • 8.1.2. Bilateral hydronephrosis
    • 8.2. Market Analysis, Insights and Forecast - by Indication
      • 8.2.1. Intrinsic
        • 8.2.1.1. Acute unilateral obstructive uropathy
        • 8.2.1.2. Kidney stone
        • 8.2.1.3. Bladder cancer
        • 8.2.1.4. Bladder stones
        • 8.2.1.5. Urethral stricture
        • 8.2.1.6. Pelvic organ prolapse
        • 8.2.1.7. Other intrinsic indications
      • 8.2.2. Extrinsic
        • 8.2.2.1. Retroperitoneal fibrosis
        • 8.2.2.2. Ovarian vein syndrome
        • 8.2.2.3. Other extrinsic indications
    • 8.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 8.3.1. Laboratory tests
        • 8.3.1.1. Urinalysis
        • 8.3.1.2. Complete blood count
        • 8.3.1.3. Electrolyte analysis
        • 8.3.1.4. Other laboratory tests
      • 8.3.2. Imaging
        • 8.3.2.1. Ultrasound
        • 8.3.2.2. Intravenous pyelography
        • 8.3.2.3. KUB X-Rays
        • 8.3.2.4. CT-scan
        • 8.3.2.5. Other imaging types
    • 8.4. Market Analysis, Insights and Forecast - by Treatment
      • 8.4.1. Shock wave lithotripsy
      • 8.4.2. Laparoscopy
      • 8.4.3. Bladder catheterization
      • 8.4.4. Steroid therapy
      • 8.4.5. Other treatment types
    • 8.5. Market Analysis, Insights and Forecast - by Age Group
      • 8.5.1. Adult
      • 8.5.2. Pediatric
  9. 9. Latin America Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 9.1. Market Analysis, Insights and Forecast - by Type
      • 9.1.1. Unilateral hydronephrosis
      • 9.1.2. Bilateral hydronephrosis
    • 9.2. Market Analysis, Insights and Forecast - by Indication
      • 9.2.1. Intrinsic
        • 9.2.1.1. Acute unilateral obstructive uropathy
        • 9.2.1.2. Kidney stone
        • 9.2.1.3. Bladder cancer
        • 9.2.1.4. Bladder stones
        • 9.2.1.5. Urethral stricture
        • 9.2.1.6. Pelvic organ prolapse
        • 9.2.1.7. Other intrinsic indications
      • 9.2.2. Extrinsic
        • 9.2.2.1. Retroperitoneal fibrosis
        • 9.2.2.2. Ovarian vein syndrome
        • 9.2.2.3. Other extrinsic indications
    • 9.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 9.3.1. Laboratory tests
        • 9.3.1.1. Urinalysis
        • 9.3.1.2. Complete blood count
        • 9.3.1.3. Electrolyte analysis
        • 9.3.1.4. Other laboratory tests
      • 9.3.2. Imaging
        • 9.3.2.1. Ultrasound
        • 9.3.2.2. Intravenous pyelography
        • 9.3.2.3. KUB X-Rays
        • 9.3.2.4. CT-scan
        • 9.3.2.5. Other imaging types
    • 9.4. Market Analysis, Insights and Forecast - by Treatment
      • 9.4.1. Shock wave lithotripsy
      • 9.4.2. Laparoscopy
      • 9.4.3. Bladder catheterization
      • 9.4.4. Steroid therapy
      • 9.4.5. Other treatment types
    • 9.5. Market Analysis, Insights and Forecast - by Age Group
      • 9.5.1. Adult
      • 9.5.2. Pediatric
  10. 10. Middle East and Africa Hydronephrosis Treatment Market Analysis, Insights and Forecast, 2019-2031
    • 10.1. Market Analysis, Insights and Forecast - by Type
      • 10.1.1. Unilateral hydronephrosis
      • 10.1.2. Bilateral hydronephrosis
    • 10.2. Market Analysis, Insights and Forecast - by Indication
      • 10.2.1. Intrinsic
        • 10.2.1.1. Acute unilateral obstructive uropathy
        • 10.2.1.2. Kidney stone
        • 10.2.1.3. Bladder cancer
        • 10.2.1.4. Bladder stones
        • 10.2.1.5. Urethral stricture
        • 10.2.1.6. Pelvic organ prolapse
        • 10.2.1.7. Other intrinsic indications
      • 10.2.2. Extrinsic
        • 10.2.2.1. Retroperitoneal fibrosis
        • 10.2.2.2. Ovarian vein syndrome
        • 10.2.2.3. Other extrinsic indications
    • 10.3. Market Analysis, Insights and Forecast - by Diagnosis
      • 10.3.1. Laboratory tests
        • 10.3.1.1. Urinalysis
        • 10.3.1.2. Complete blood count
        • 10.3.1.3. Electrolyte analysis
        • 10.3.1.4. Other laboratory tests
      • 10.3.2. Imaging
        • 10.3.2.1. Ultrasound
        • 10.3.2.2. Intravenous pyelography
        • 10.3.2.3. KUB X-Rays
        • 10.3.2.4. CT-scan
        • 10.3.2.5. Other imaging types
    • 10.4. Market Analysis, Insights and Forecast - by Treatment
      • 10.4.1. Shock wave lithotripsy
      • 10.4.2. Laparoscopy
      • 10.4.3. Bladder catheterization
      • 10.4.4. Steroid therapy
      • 10.4.5. Other treatment types
    • 10.5. Market Analysis, Insights and Forecast - by Age Group
      • 10.5.1. Adult
      • 10.5.2. Pediatric
  11. 11. Competitive Analysis
    • 11.1. Global Market Share Analysis 2024
      • 11.2. Company Profiles
        • 11.2.1 AbbVie Inc
          • 11.2.1.1. Overview
          • 11.2.1.2. Products
          • 11.2.1.3. SWOT Analysis
          • 11.2.1.4. Recent Developments
          • 11.2.1.5. Financials (Based on Availability)
        • 11.2.2 Amgen Inc
          • 11.2.2.1. Overview
          • 11.2.2.2. Products
          • 11.2.2.3. SWOT Analysis
          • 11.2.2.4. Recent Developments
          • 11.2.2.5. Financials (Based on Availability)
        • 11.2.3 The Anthem Group
          • 11.2.3.1. Overview
          • 11.2.3.2. Products
          • 11.2.3.3. SWOT Analysis
          • 11.2.3.4. Recent Developments
          • 11.2.3.5. Financials (Based on Availability)
        • 11.2.4 F. Hoffmann-La Roche Ltd
          • 11.2.4.1. Overview
          • 11.2.4.2. Products
          • 11.2.4.3. SWOT Analysis
          • 11.2.4.4. Recent Developments
          • 11.2.4.5. Financials (Based on Availability)
        • 11.2.5 Nephrogenex Inc.
          • 11.2.5.1. Overview
          • 11.2.5.2. Products
          • 11.2.5.3. SWOT Analysis
          • 11.2.5.4. Recent Developments
          • 11.2.5.5. Financials (Based on Availability)
        • 11.2.6 Novartis AG
          • 11.2.6.1. Overview
          • 11.2.6.2. Products
          • 11.2.6.3. SWOT Analysis
          • 11.2.6.4. Recent Developments
          • 11.2.6.5. Financials (Based on Availability)
        • 11.2.7 Pfizer Inc.
          • 11.2.7.1. Overview
          • 11.2.7.2. Products
          • 11.2.7.3. SWOT Analysis
          • 11.2.7.4. Recent Developments
          • 11.2.7.5. Financials (Based on Availability)
        • 11.2.8 Phraxis Inc.
          • 11.2.8.1. Overview
          • 11.2.8.2. Products
          • 11.2.8.3. SWOT Analysis
          • 11.2.8.4. Recent Developments
          • 11.2.8.5. Financials (Based on Availability)
        • 11.2.9 Renal Associates P.A.
          • 11.2.9.1. Overview
          • 11.2.9.2. Products
          • 11.2.9.3. SWOT Analysis
          • 11.2.9.4. Recent Developments
          • 11.2.9.5. Financials (Based on Availability)
        • 11.2.10 Sanofi
          • 11.2.10.1. Overview
          • 11.2.10.2. Products
          • 11.2.10.3. SWOT Analysis
          • 11.2.10.4. Recent Developments
          • 11.2.10.5. Financials (Based on Availability)
List of Figures
  1. Figure 1: Global Hydronephrosis Treatment Market Revenue Breakdown (Billion, %) by Region 2024 & 2032
  2. Figure 2: North America Hydronephrosis Treatment Market Revenue (Billion), by Type 2024 & 2032
  3. Figure 3: North America Hydronephrosis Treatment Market Revenue Share (%), by Type 2024 & 2032
  4. Figure 4: North America Hydronephrosis Treatment Market Revenue (Billion), by Indication 2024 & 2032
  5. Figure 5: North America Hydronephrosis Treatment Market Revenue Share (%), by Indication 2024 & 2032
  6. Figure 6: North America Hydronephrosis Treatment Market Revenue (Billion), by Diagnosis 2024 & 2032
  7. Figure 7: North America Hydronephrosis Treatment Market Revenue Share (%), by Diagnosis 2024 & 2032
  8. Figure 8: North America Hydronephrosis Treatment Market Revenue (Billion), by Treatment 2024 & 2032
  9. Figure 9: North America Hydronephrosis Treatment Market Revenue Share (%), by Treatment 2024 & 2032
  10. Figure 10: North America Hydronephrosis Treatment Market Revenue (Billion), by Age Group 2024 & 2032
  11. Figure 11: North America Hydronephrosis Treatment Market Revenue Share (%), by Age Group 2024 & 2032
  12. Figure 12: North America Hydronephrosis Treatment Market Revenue (Billion), by Country 2024 & 2032
  13. Figure 13: North America Hydronephrosis Treatment Market Revenue Share (%), by Country 2024 & 2032
  14. Figure 14: Europe Hydronephrosis Treatment Market Revenue (Billion), by Type 2024 & 2032
  15. Figure 15: Europe Hydronephrosis Treatment Market Revenue Share (%), by Type 2024 & 2032
  16. Figure 16: Europe Hydronephrosis Treatment Market Revenue (Billion), by Indication 2024 & 2032
  17. Figure 17: Europe Hydronephrosis Treatment Market Revenue Share (%), by Indication 2024 & 2032
  18. Figure 18: Europe Hydronephrosis Treatment Market Revenue (Billion), by Diagnosis 2024 & 2032
  19. Figure 19: Europe Hydronephrosis Treatment Market Revenue Share (%), by Diagnosis 2024 & 2032
  20. Figure 20: Europe Hydronephrosis Treatment Market Revenue (Billion), by Treatment 2024 & 2032
  21. Figure 21: Europe Hydronephrosis Treatment Market Revenue Share (%), by Treatment 2024 & 2032
  22. Figure 22: Europe Hydronephrosis Treatment Market Revenue (Billion), by Age Group 2024 & 2032
  23. Figure 23: Europe Hydronephrosis Treatment Market Revenue Share (%), by Age Group 2024 & 2032
  24. Figure 24: Europe Hydronephrosis Treatment Market Revenue (Billion), by Country 2024 & 2032
  25. Figure 25: Europe Hydronephrosis Treatment Market Revenue Share (%), by Country 2024 & 2032
  26. Figure 26: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Type 2024 & 2032
  27. Figure 27: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Type 2024 & 2032
  28. Figure 28: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Indication 2024 & 2032
  29. Figure 29: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Indication 2024 & 2032
  30. Figure 30: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Diagnosis 2024 & 2032
  31. Figure 31: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Diagnosis 2024 & 2032
  32. Figure 32: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Treatment 2024 & 2032
  33. Figure 33: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Treatment 2024 & 2032
  34. Figure 34: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Age Group 2024 & 2032
  35. Figure 35: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Age Group 2024 & 2032
  36. Figure 36: Asia Pacific Hydronephrosis Treatment Market Revenue (Billion), by Country 2024 & 2032
  37. Figure 37: Asia Pacific Hydronephrosis Treatment Market Revenue Share (%), by Country 2024 & 2032
  38. Figure 38: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Type 2024 & 2032
  39. Figure 39: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Type 2024 & 2032
  40. Figure 40: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Indication 2024 & 2032
  41. Figure 41: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Indication 2024 & 2032
  42. Figure 42: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Diagnosis 2024 & 2032
  43. Figure 43: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Diagnosis 2024 & 2032
  44. Figure 44: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Treatment 2024 & 2032
  45. Figure 45: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Treatment 2024 & 2032
  46. Figure 46: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Age Group 2024 & 2032
  47. Figure 47: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Age Group 2024 & 2032
  48. Figure 48: Latin America Hydronephrosis Treatment Market Revenue (Billion), by Country 2024 & 2032
  49. Figure 49: Latin America Hydronephrosis Treatment Market Revenue Share (%), by Country 2024 & 2032
  50. Figure 50: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Type 2024 & 2032
  51. Figure 51: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Type 2024 & 2032
  52. Figure 52: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Indication 2024 & 2032
  53. Figure 53: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Indication 2024 & 2032
  54. Figure 54: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Diagnosis 2024 & 2032
  55. Figure 55: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Diagnosis 2024 & 2032
  56. Figure 56: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Treatment 2024 & 2032
  57. Figure 57: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Treatment 2024 & 2032
  58. Figure 58: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Age Group 2024 & 2032
  59. Figure 59: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Age Group 2024 & 2032
  60. Figure 60: Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion), by Country 2024 & 2032
  61. Figure 61: Middle East and Africa Hydronephrosis Treatment Market Revenue Share (%), by Country 2024 & 2032
List of Tables
  1. Table 1: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Region 2019 & 2032
  2. Table 2: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  3. Table 3: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  4. Table 4: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  5. Table 5: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  6. Table 6: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  7. Table 7: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Region 2019 & 2032
  8. Table 8: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  9. Table 9: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  10. Table 10: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  11. Table 11: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  12. Table 12: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  13. Table 13: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Country 2019 & 2032
  14. Table 14: U.S. Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  15. Table 15: Canada Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  16. Table 16: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  17. Table 17: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  18. Table 18: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  19. Table 19: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  20. Table 20: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  21. Table 21: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Country 2019 & 2032
  22. Table 22: Germany Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  23. Table 23: UK Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  24. Table 24: France Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  25. Table 25: Italy Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  26. Table 26: Spain Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  27. Table 27: Rest of Europe Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  28. Table 28: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  29. Table 29: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  30. Table 30: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  31. Table 31: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  32. Table 32: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  33. Table 33: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Country 2019 & 2032
  34. Table 34: China Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  35. Table 35: Japan Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  36. Table 36: India Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  37. Table 37: Australia Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  38. Table 38: South Korea Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  39. Table 39: Rest of Asia Pacific Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  40. Table 40: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  41. Table 41: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  42. Table 42: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  43. Table 43: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  44. Table 44: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  45. Table 45: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Country 2019 & 2032
  46. Table 46: Brazil Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  47. Table 47: Mexico Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  48. Table 48: Argentina Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  49. Table 49: Rest of Latin America Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  50. Table 50: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Type 2019 & 2032
  51. Table 51: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Indication 2019 & 2032
  52. Table 52: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Diagnosis 2019 & 2032
  53. Table 53: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Treatment 2019 & 2032
  54. Table 54: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Age Group 2019 & 2032
  55. Table 55: Global Hydronephrosis Treatment Market Revenue Billion Forecast, by Country 2019 & 2032
  56. Table 56: Saudi Arabia Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  57. Table 57: South Africa Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  58. Table 58: UAE Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032
  59. Table 59: Rest of Middle East and Africa Hydronephrosis Treatment Market Revenue (Billion) Forecast, by Application 2019 & 2032

STEP 1 - Identification of Relevant Samples Size from Population Database

Step Chart
bar chart
method chart

STEP 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)

approach chart
Top-down and bottom-up approaches are used to validate the global market size and estimate the market size for manufactures, regional segemnts, product and application.

Note* : In applicable scenarios

STEP 3 - Data Sources

Primary Research

  • Web Analytics
  • Survey Reports
  • Research Institute
  • Latest Research Reports
  • Opinion Leaders

Secondary Research

  • Annual Reports
  • White Paper
  • Latest Press Release
  • Industry Association
  • Paid Database
  • Investor Presentations
approach chart

STEP 4 - Data Triangulation

Involves using different sources of information in order to increase the validity of a study

These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.

Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.

During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence

Additionally after gathering mix and scattered data from wide range of sources, data is triangull- ated and correlated to come up with estimated figures which are further validated through primary mediums, or industry experts, opinion leader.

Frequently Asked Questions

What are some drivers contributing to market growth?

Rising prevalence of kidney diseases., Increasing patient population related to urinary tract infections., Growing demand for minimally invasive procedures., Increasing adoption of advanced imaging techniques for diagnosis.

Can you provide examples of recent developments in the market?

In June 2023, Novartis AG bolstered its innovative medicines strategy and renal pipeline by acquiring Chinook Therapeutics. This acquisition may expand the company’s drug portfolio to target kidney disease treatment.

Are there any additional resources or data provided in the report?

While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.

Are there any specific market keywords associated with the report?

Yes, the market keyword associated with the report is "Hydronephrosis Treatment Market," which aids in identifying and referencing the specific market segment covered.

Is the market size provided in terms of value or volume?

The market size is provided in terms of value, measured in Billion .

What pricing options are available for accessing the report?

Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4,850 , USD 5,350, and USD 8,350 respectively.

Can you provide details about the market size?

The market size is estimated to be USD 2.4 Billion as of 2022.

What is the projected Compound Annual Growth Rate (CAGR) of the Hydronephrosis Treatment Market ?

The projected CAGR is approximately 8.2%.

Related Reports

See the similar reports

Discover the Latest Market Insight Reports

Access in-depth insights on industries, companies, trends, and global markets. Our expertly curated reports provide the most relevant data and analysis in a condensed, easy-to-read format.

shop image 1

About Market Insights Report

Market Insights Reports offers comprehensive market research reports and analysis, giving businesses important information about their clients, rivals, and sector to help them make well-informed decisions on operations, marketing, and business strategy. We offer a variety of services in addition to market research, data analysis, and strategy planning. In order to find opportunities and learn more about our competitors and the industry at large, we employ competitive analysis. To identify areas for development, we also evaluate our performance against that of our rivals. We can determine the places at which we can offer our clients the most value by performing value chain analysis.

Additionally, clients receive a thorough overview of their industry business environment. We can find trends that help us forecast future possibilities and threats by examining global macroeconomic dynamics and consumer behavior patterns. By analyzing their features and advantages, contrasting them with comparable items on the market, and evaluating both their quantitative and qualitative performance, we comprehensively evaluate our clients' products. This allows us to assist customers in determining how their goods compare to those of their rivals and in creating successful marketing plans. Our group has been successful in gaining a thorough grasp of our clients' requirements and offering them creative solutions. We currently provide services to more than 50 nations in Europe, the Middle East, Africa, Latin America, Asia Pacific, and North America. Because of our global reach, we have been able to establish trusting bonds with our partners and clients in various nations, improving customer service and forging a more cohesive worldwide presence.

We use cookies to enhance your experience.

By clicking "Accept All", you consent to the use of all cookies.

Customize your preferences or read our Cookie Policy.